Your browser doesn't support javascript.
loading
Medical abortion in primary care: pitfalls and benefits / Aborto medico en la atención primaria: riesgos y beneficios
Boersma, AA; Meyboom-de Jong, B.
Affiliation
  • Boersma, AA; University of Groningen. NL
  • Meyboom-de Jong, B; University of Groningen. NL
West Indian med. j ; 58(6): 610-613, Dec. 2009.
Article in English | LILACS | ID: lil-672553
Responsible library: BR1.1
ABSTRACT
We describe five pitfalls of medical abortion ectopic pregnancy not terminated after misoprostol, but without negative side-effects; long-term vaginal blood loss with suspicious retained products which disappeared spontaneously; a patient with uterus myomatatosus with severe pain and retained products in the uterus; repetition of misoprostol because of retained products in the uterus after two weeks and an allergic reaction to methotrexate. Despite these pitfalls, there are enough benefits to consider medical abortion with methotrexate and misoprostol as a safe method with a high success rate of more than 91% and a good alternative for surgical abortion. An invasive procedure is not necessary, there are no long-term complications and it can be performed at an earlier stage, which makes it more acceptable in society. In Curaçao, where abortion is legally restricted, medical abortion is performed with methotrexate and misoprostol. In countries where abortion is legal, mifepristone and misoprostol are the first choice.
RESUMEN
Describimos cinco riesgos del aborto medico el embrazo ectópico no terminado después de misoprostol, pero sin efectos secundarios negativos; la pérdida de sangre vaginal a largo plazo sin productos retenidos sospechosos que desaparecieron espontáneamente; una paciente con útero miomatoso con dolor severo y productos retenidos en el útero; repetición del misoprostol debido a productos retenidos en el útero después de dos semanas y una reacción alérgica al metotrexato. A pesar de estas dificultades, hay suficientes beneficios para considerar el aborto médico con metotrexato y misoprostol como un método seguro con una alta tasa de éxito superior al 91%, y como una buena alternativa al aborto quirúrgico. No se requiere un procedimiento invasivo, no hay complicaciones a largo plazo, y puede realizarse en una etapa más temprana, lo que resulta más aceptable para la sociedad. En Curazao, donde el aborto está legalmente restringido, el aborto médico se realiza con metotrexato y misoprostol. En países donde el aborto es legal, la mefepristona y el misoprostol son la primera elección.
Subject(s)
Full text: Available Collection: International databases Health context: SDG3 - Health and Well-Being Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: LILACS Main subject: Abortifacient Agents / Misoprostol / Abortion, Induced Limits: Adult / Female / Humans / Pregnancy Language: English Journal: West Indian med. j Journal subject: Medicine Year: 2009 Document type: Article Affiliation country: Netherlands Institution/Affiliation country: University of Groningen/NL
Full text: Available Collection: International databases Health context: SDG3 - Health and Well-Being Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: LILACS Main subject: Abortifacient Agents / Misoprostol / Abortion, Induced Limits: Adult / Female / Humans / Pregnancy Language: English Journal: West Indian med. j Journal subject: Medicine Year: 2009 Document type: Article Affiliation country: Netherlands Institution/Affiliation country: University of Groningen/NL
...